8-K: Health In Tech Announces Executive Transition

Dustin Plantholt departs as Chief AI & Marketing Officer, transitioning to an independent consulting role.

Summary

• Dustin Plantholt will depart his role as Chief AI & Marketing Officer of Health In Tech, Inc., effective April 30, 2026.
• The departure is part of a business transition and not due to any disagreement regarding operations, policies, or practices.
• HITChain Inc., a subsidiary, has entered into a consulting agreement with Plantholt Advisory Group LLC, effective May 1, 2026.
• The consultant will receive $28,333.33 per month for services related to the 'AskTim' AI platform and ZKP technology integration.
• The consultant will receive 500,000 restricted shares of HITChain common stock, vesting in equal monthly installments over 12 months.

Sentiment

Score: 5

Explanation: StockSavvy.ai views this as a neutral administrative transition; while it retains key talent, it reflects a change in the executive leadership structure.

Positives

• Ensures continuity of technical and project management expertise for the 'AskTim' AI platform development.
• Maintains access to key personnel through a structured independent contractor agreement.
• The transition is amicable and explicitly stated as not resulting from operational disagreements.

Negatives

• Loss of a C-suite executive role, potentially signaling a shift in internal leadership structure.
• Additional equity dilution through the issuance of 500,000 restricted shares to the consultant.

Risks

• Dependency on a single 'Key Person' (Dustin Plantholt) for critical project milestones.
• Potential for project delays if the consultant fails to meet performance metrics or delivery schedules.
• Termination of the agreement by either party requires only 10 days' notice, creating potential operational instability.

Future Outlook

The company is focused on a three-phase implementation project for its 'AskTim' AI-powered benefits counselor, including backend infrastructure, TypeScript-based Health Data SDK integration, and ZKP technology implementation.

Management Comments

• The departure is part of a business transition and not as a result of any disagreement with the Company on any matter relating to its operations, policies or practices.

Industry Context

StockSavvy.ai notes that the shift from executive roles to consulting arrangements is a common strategy for tech firms looking to retain specialized technical knowledge while streamlining C-suite overhead during product development phases.

Comparison to Industry Standards

• The use of restricted stock awards for consultants is standard practice in the technology sector to align contractor incentives with long-term company performance.
• The 10-day termination for convenience clause is relatively short, reflecting a high-risk, high-agility approach common in early-stage AI development projects.

Management Changes

Corporate Governance

Related Party Transactions

• Consulting agreement with Plantholt Advisory Group LLC, an entity owned and controlled by former officer Dustin Plantholt.

Stakeholder Impact

• Shareholders: Potential dilution from the issuance of 500,000 restricted shares.
• Employees: Continued collaboration with Dustin Plantholt in a consulting capacity.

Next Steps

• Execution of the three-phase implementation project for 'AskTim'.
• Monthly vesting of the 500,000 restricted shares over the next 12 months.
• Ongoing performance monitoring against milestones defined in the Consulting Agreement.

Key Dates

Recommendation

The filing represents a routine executive transition and does not fundamentally alter the company's financial position or strategic direction, warranting a hold position until further operational progress is reported.

Keywords

Health In Tech, HIT, Executive Transition, AI, AskTim, HITChain, Consulting Agreement, ZKP